Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
Justin You, Mohieldin Youssef, Jhune Rizsan Santos, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1307-1307
Open Access | Times Cited: 23

Showing 23 citing articles:

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 89
Reactive gliosis in traumatic brain injury: a comprehensive review
Zuzana Amlerova, Martina Chmelová, Miroslava Andĕrová, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 15
Emerging Targets in Amyotrophic lateral sclerosis (ALS): The Promise of ATP-Binding Cassette (ABC) transporter Modulation
Maneesh Mohan, Ashi Mannan, Aayush Nauriyal, et al.
Behavioural Brain Research (2024) Vol. 476, pp. 115242-115242
Closed Access | Times Cited: 9
New insight on microglia activation in neurodegenerative diseases and therapeutics
Yucong Xu, Wei Gao, Yingnan Sun, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 16
High-Fat Diet—Shared Environmental Risk Factor for Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Thomas Gabriel Schreiner, L Iacob, Cristina Croitoru, et al.
Sclerosis (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access
Neuronal TDP-43 aggregation drives changes in microglial morphology prior to immunophenotype in amyotrophic lateral sclerosis
Molly E. V. Swanson, Miran Mrkela, Clinton Turner, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Neural Excitatory/Inhibitory Imbalance in Motor Aging: From Genetic Mechanisms to Therapeutic Challenges
Xuhui Chen, Ya Wang, Yongning Zhang, et al.
Biology (2025) Vol. 14, Iss. 3, pp. 272-272
Open Access
Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols
Annamaria Russo, Stefano Putaggio, Ester Tellone, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1211-1211
Open Access
Rare Diseases, Spotlighting Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Myasthenia Gravis: Insights from Landscape Analysis of Current Research
Kavita A. Iyer, Rumiana Koynova, Janet M. Sasso, et al.
Biochemistry (2025)
Closed Access
Role of Antioxidants in Modulating the Microbiota–Gut–Brain Axis and Their Impact on Neurodegenerative Diseases
Natalia Kurhaluk, Piotr Kamiński, Rafał Bilski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3658-3658
Open Access
Role of glial cells in motor neuron degeneration in hereditary spastic paraplegias
Manaswini Vijayaraghavan, S. R. Murali, Gitika Thakur, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Exploring the Significance of Microglial Phenotypes and Morphological Diversity in Neuroinflammation and Neurodegenerative Diseases: From Mechanisms to Potential Therapeutic Targets
Mai M. Anwar, Leonor Pérez‐Martínez, Gustavo Pedraza‐Alva
Immunological Investigations (2024) Vol. 53, Iss. 6, pp. 891-946
Closed Access | Times Cited: 3
Elucidation of the role of microglia‐macrophage‐based neuroinflammation in neurological diseases
Ryo Yamasaki
Neurology and Clinical Neuroscience (2024) Vol. 12, Iss. 6, pp. 329-339
Open Access | Times Cited: 2
Rare diseases, spotlighting amyotrophic lateral sclerosis, Huntington’s disease, and myasthenia gravis: Insights from landscape analysis of current research
Kavita A. Iyer, Rumiana Tenchov, Janet M. Sasso, et al.
(2024)
Open Access | Times Cited: 2
Knockout of Dectin-1 does not modify disease onset or progression in a MATR3 S85C knock-in mouse model of ALS
Justin You, Katarina Maksimovic, Karin Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis
Shishi Jiang, Renshi Xu
Molecular Neurobiology (2024)
Closed Access
Respiratory pathology in the TDP-43 transgenic mouse model of amyotrophic lateral sclerosis
Debolina D. Biswas, Ronit Sethi, Yochebed Woldeyohannes, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access
Knockout of Dectin-1 does not modify disease onset or progression in a MATR3 S85C knock-in mouse model of ALS
Justin You, Katarina Maksimovic, Mark N Metri, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37926-e37926
Open Access
Gasdermin D is activated but does not drive neurodegeneration in SOD1G93A model of ALS: Implications for targeting pyroptosis
Georgia Gunner, Himanish Basu, Yong Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Scientific and Therapeutic Rationale for Off‐Label Treatments in Amyotrophic Lateral Sclerosis
Richard Bedlack, Xiaoyan Li, Baggio Evangelista, et al.
Annals of Neurology (2024)
Open Access
Theme 3 In Vitro Experimental Models

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2024) Vol. 25, Iss. sup1, pp. 122-135
Closed Access
Plant derived bioactive compounds for the treatment of neurodegeneration and neuroimmune disorders associated with the complement system
Jeyaparthasarathy Narayanaperumal, Ganesh Gopal
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 744-769
Open Access
Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
Xiaofeng Fu, Huimin Cai, Shuiyue Quan, et al.
Medical Review (2024)
Open Access
Page 1

Scroll to top